Rankings
▼
Calendar
▼
FLNA FY 2022 Earnings Report — Filana Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
Filana Therapeutics, Inc.
FLNA
FY 2022 Earnings
Reported December 31, 2022
Quarter Comparison
Revenue
Operating Income
EPS (Diluted)
Metric
FY 2022
Prior Q
FY 2021
QoQ Change
YoY Change
Revenue
$0
—
$0
—
—
Op. Income
-$80M
—
-$33M
—
-143.5%
EPS (Diluted)
$-1.90
—
$-0.82
—
-131.7%
marketcaparena.com
Income Statement
Item
Amount
REVENUE
$0
Cost of Revenue
$0
GROSS PROFIT
$0
R&D Expenses
$68M
Selling & Marketing
$0
General & Administrative
$12M
SG&A Expenses
$12M
Other Expenses
$0
Operating Expenses
$80M
Cost & Expenses
$80M
OPERATING INCOME
-$80M
Interest Income
$3M
Interest Expense
$0
Other Income/Expenses
$4M
INCOME BEFORE TAX
-$76M
Income Tax Expense
$0
Net Income from Continuing Ops
-$76M
Net Income from Discontinued Ops
$0
Other Adjustments
$0
NET INCOME
-$76M
Net Income Deductions
$0
BOTTOM LINE NET INCOME
-$76M
D&A
$1M
EBIT
-$81M
EBITDA
-$80M
EPS
-$2
EPS Diluted
-$2
marketcaparena.com
← FY 2021
FLNA Overview
FY 2023 →